Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Reducing the CV Risks of Smoking
10
Mins
December 2024
Smoking is a major risk factor for cardiovascular disease (CVD) and responsible for around 25% of all CVD-related deaths worldwide…
Read more
8
Mins
20 Oct 2020
New Insights into Icosapent Ethyl for Patients with Residual Cardiovascular Risk
REDUCE-IT was a Phase IIIb, double-blind, placebo-controlled trial that randomised 8,179 patients to receive icosapent ethyl (4 g/day) or placebo…
2
Mins
20 Oct 2020
First Clinical Validation of the 0-Hour/1-Hour Algorithm Using High-Sensitivity Cardiac Troponin I for the Diagnosis of Acute Myocardial Infarction in Japanese Patients
Acute myocardial infarction (AMI) is a common and life-threating condition. Approximately 10% of all emergency department (ED)…
5
Mins
20 Oct 2020
Key Findings from the EXPLORER-HCM Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy: Insights From the Principal Investigator
Hypertrophic cardiomyopathy (HCM) is a progressive myocardial disease that impacts function and quality of life. Patients…
4
Mins
20 Oct 2020
Interview: Dr Rasha Al-Lamee
I went into cardiology to combine the science of medicine and the practical skills of surgery. I enjoy finding a problem and doing my best to fix it…
10
Mins
20 Oct 2020
Editor’s Pick: Artificial Intelligence in Patients with Congenital Heart Disease: Where Do We Stand?
Life expectancy of patients with congenital heart disease (CHD) has increased in recent decades; however, late complications remain frequent and…
10
Mins
20 Oct 2020
Sex Differences in Heart Failure with Preserved Ejection Fraction Therapy: Potential Mechanisms and Clinical Implications
This paper highlights some key differences between females and males with heart failure with a preserved ejection fraction, discusses clinical trials assessing treatments, and proposes what is needed to target HFpEF care according to sex.
5
Mins
20 Oct 2020
Acute Severe Mitral Regurgitation Secondary to
Haemophilus parainfluenzae
Infective Endocarditis
Haemophilus parainfluenzae has established itself as an important, albeit uncommon, cause of infective endocarditis (IE)…
10
Mins
20 Oct 2020
The Evolution and Future Direction of The Cardiac Biomarker
The use of biomarkers has become routine in many areas of medicine. Knowing how and why these became incorporated into medical practice…
Loading posts...
« Previous
1
…
8
9
10
11
12
…
24
Next »